Skip to content
10-Q

Quarterly Report

VYCOR MEDICAL, INC. VYCO

0001493152-23-040566

← back to feed
Filed
Nov 13, 2023 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2023 · Nov 13, 2023 32.63M sh
Shares Diluted Q3 2023 · Sep 30, 2023 32.63M sh
Shares Diluted Q3 2023 · Sep 30, 2023 32.6M sh
Shares Diluted Q3 2023 · Sep 30, 2022 32M sh
Shares Diluted Q3 2023 · Sep 30, 2022 31.43M sh
Cash And Equivalents Q3 2023 · Sep 30, 2023 $69.06K
Cash And Equivalents Q3 2023 · Dec 31, 2022 $37.04K
Current Liabilities Q3 2023 · Sep 30, 2023 $4.03M
Current Liabilities Q3 2023 · Dec 31, 2022 $3.65M
Total Liabilities Q3 2023 · Sep 30, 2023 $4.29M
Total Liabilities Q3 2023 · Dec 31, 2022 $3.8M
Current Assets Q3 2023 · Sep 30, 2023 $625.89K
Current Assets Q3 2023 · Dec 31, 2022 $517.76K
Total Assets Q3 2023 · Sep 30, 2023 $1.05M
Total Assets Q3 2023 · Dec 31, 2022 $860.18K
Operating Cash Flow Q3 2023 · Sep 30, 2022 −$183.66K
Stockholders Equity Q3 2023 · Sep 30, 2022 −$2.82M
Stockholders Equity Q3 2023 · Jun 30, 2022 −$2.6M
Stockholders Equity restated Q3 2023 · Dec 31, 2021 $2.4M
Eps Diluted Q3 2023 · Sep 30, 2022 −$0.01
Eps Diluted Q3 2023 · Sep 30, 2022 −$0.02
Eps Basic Q3 2023 · Sep 30, 2022 −$0.01
Eps Basic Q3 2023 · Sep 30, 2022 −$0.02
Sga Expense Q3 2023 · Sep 30, 2022 $341.26K
Sga Expense Q3 2023 · Sep 30, 2022 $1.02M
Net Income Q3 2023 · Sep 30, 2022 −$114.81K
Net Income Q3 2023 · Sep 30, 2022 −$288.37K
Operating Income Q3 2023 · Sep 30, 2022 −$88.05K
Operating Income Q3 2023 · Sep 30, 2022 −$215.32K
Gross Profit Q3 2023 · Sep 30, 2022 $267.77K
Gross Profit Q3 2023 · Sep 30, 2022 $848.23K
Cost Of Revenue Q3 2023 · Sep 30, 2022 $42.2K
Cost Of Revenue Q3 2023 · Sep 30, 2022 $103.49K
Revenue Q3 2023 · Sep 30, 2022 $309.97K
Revenue Q3 2023 · Sep 30, 2022 $951.73K